Board of the Pension Protection Fund raised its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 86.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,700 shares of the company's stock after purchasing an additional 8,200 shares during the period. Docusign accounts for approximately 1.5% of Board of the Pension Protection Fund's holdings, making the stock its 28th biggest holding. Board of the Pension Protection Fund's holdings in Docusign were worth $1,379,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Banque Transatlantique SA acquired a new stake in shares of Docusign in the 1st quarter valued at approximately $26,000. Hemington Wealth Management raised its position in shares of Docusign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after acquiring an additional 264 shares during the period. Golden State Wealth Management LLC raised its position in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after acquiring an additional 322 shares during the period. Summit Securities Group LLC acquired a new stake in shares of Docusign in the 1st quarter valued at approximately $34,000. Finally, Rise Advisors LLC raised its position in shares of Docusign by 864.6% in the 1st quarter. Rise Advisors LLC now owns 463 shares of the company's stock valued at $38,000 after acquiring an additional 415 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, insider James P. Shaughnessy sold 7,500 shares of the business's stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total transaction of $533,925.00. Following the transaction, the insider directly owned 55,442 shares in the company, valued at approximately $3,946,915.98. The trade was a 11.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the business's stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $69.69, for a total transaction of $2,787,600.00. Following the transaction, the chief executive officer owned 136,246 shares in the company, valued at approximately $9,494,983.74. The trade was a 22.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 102,533 shares of company stock valued at $7,709,933 over the last ninety days. Insiders own 1.01% of the company's stock.
Analysts Set New Price Targets
DOCU has been the topic of a number of analyst reports. Royal Bank Of Canada increased their price target on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research report on Friday, September 5th. Wells Fargo & Company increased their price target on shares of Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research report on Friday, September 5th. Wall Street Zen upgraded shares of Docusign from a "hold" rating to a "buy" rating in a research report on Saturday, September 13th. JPMorgan Chase & Co. increased their price target on shares of Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Finally, Robert W. Baird increased their price target on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have assigned a Hold rating to the company. Based on data from MarketBeat, Docusign currently has a consensus rating of "Hold" and a consensus price target of $94.14.
Read Our Latest Research Report on DOCU
Docusign Stock Down 4.1%
NASDAQ DOCU opened at $68.40 on Friday. Docusign Inc. has a 12-month low of $66.35 and a 12-month high of $107.86. The company has a market capitalization of $13.76 billion, a PE ratio of 51.43, a price-to-earnings-growth ratio of 3.40 and a beta of 1.02. The firm's 50 day moving average is $75.48 and its 200-day moving average is $78.45.
Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same period last year, the company earned $0.97 earnings per share. The firm's revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, sell-side analysts expect that Docusign Inc. will post 1.17 EPS for the current year.
About Docusign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.